GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Insurance INS

Support legislation to continue funding for the Child Health Insurance Program.

Contacted: Homeland Security, Dept of (DHS); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); White House Office; Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Health Issues HCR

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller bill, and the FY 2017 budget resolution (S. Con. Res. 3). Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Provided comments to SAMHSA regarding its final rule modifying the regulations at 42 CFR Part 2. Advocate for continuation of ACA CSR subsidy payments. Support for streamlining HIPAA requirements in a letter to the HHS Office for Civil Rights. Comments on the FY 2018 IPPS proposed rule (CMS-1677-P) re: electronic health record incentive program modifications.

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); SENATE; Homeland Security, Dept of (DHS); White House Office; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: S.Con.Res. 3 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and the Better Care Reconciliation Act (Senate) (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (support) (H.R.2267/S.1301). Oppose the continuation of Medicaid Disproportionate Share Hospital (DSH) cuts. The Empire State Equity Act (H.R. 2088) - support. Provide comments to CMS on the Medicare IPPS FY 2018 proposed rule (CMS-1677-P), advocate for a delay of proposed rule section dealing with DSH uncompensated care pool, and comments regarding Medicare quality reporting program proposals. Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose. Oppose legislation and regulations that would harm 340B program, including proposal in the 2018 proposed OPPS rule (CMS-1678-P) reducing Medicare reimbursment for certain 340B drugs. Provided comments to CMS on the 2018 OPPS proposed rule (CMS-1678-P) addressing payments to off-campus hospital outpatient departments. Support Federal funding for Puerto Rico's Medicaid program and for Medicaid for individuals and families displaced by hurricanes (H.R.2266 - Additional Supplemental Appropriations for Disaster Relief Requirements Act, 2017, H.R.601 - Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017.)

Contacted: Drug Enforcement Administration (DEA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Homeland Security, Dept of (DHS); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA)

Bills named: H.R. 601 (115th), H.R. 2267 (115th), H.R. 1628 (115th), S.Con.Res. 3 (115th), H.R. 2266 (115th), S. 1301 (115th), H.R. 2088 (115th)

Budget/Appropriations BUD

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and Better Care Reconciliation Act (Senate) (budget reconciliation bill, H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Oppose funding cuts for the NIH included in President Trumps FY 18 budget proposal (America First: A Budget Blueprint to Make America Great Again). Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose.

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Homeland Security, Dept of (DHS)

Bills named: H.R. 1628 (115th), S.Con.Res. 3 (115th)

Pharmacy PHA

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases. Support drug pricing legislation that would promote competition by fast tracking generic drug applications (H.R. 749/S.297). Oppose legislation that would harm the 340B drug discount program for safety net hospitals. Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214)

Contacted: Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); White House Office; Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 944 (115th), H.R. 2214 (115th), H.R. 749 (115th), S. 297 (115th), S. 124 (115th)

Immigration IMM

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Contacted: Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; White House Office; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)